Clinical Trials Directory

Trials / Unknown

UnknownNCT03813823

Biobehavioral Correlates of Acute Phobic Fear

Biobehavioral Correlates of Acute Phobic Fear: Proinflammatory, Autonomic, and Neurocognitive Outcomes

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
University of Colorado, Boulder · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study seeks to measure the time course of circulating proinflammatory markers (interleukin-1 beta \[IL-1β\], interleukin-6 \[IL-6\], tumor necrosis factor alpha \[TNF-α\], and C-reactive protein \[CRP\]) and salivary alpha amylase (sAA) following laboratory fear arousal. Further, this study seeks to implement neurocognitive, physiological, and self-report measures to explore the role of threat sensitivity as a predictor of this response. The broad research question seeks to better understand the relationship between neurocognitive fear and subsequent stress responding elicited by both the immune system (i.e., proinflammatory markers) and autonomic nervous system (i.e., sAA). In light of these aims, the primary outcomes of the current study are the proinflammatory markers (IL-1β, IL-6, TNF-α, CRP), while secondary outcomes consist of sAA, neurocognitive measures (i.e., dot-probe task), physiological correlates (i.e., heart rate, galvanic skin response), and self-report measures.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFear tasksAll participants will be exposed to 5 fear tasks involving spiders, with increasing fear intensity.

Timeline

Start date
2019-02-04
Primary completion
2019-08-01
Completion
2019-08-01
First posted
2019-01-23
Last updated
2019-01-23

Source: ClinicalTrials.gov record NCT03813823. Inclusion in this directory is not an endorsement.